Ureterolithiasis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: URT014 MIFTS: 44	Ureterolithiasis Categories: Nephrological diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Ureterolithiasis

MalaCards integrated aliases for Ureterolithiasis:

Name: Ureterolithiasis ¹¹ ⁴³ ¹⁴ ¹⁶ ⁷¹ ⁷⁵ ³³

Calculus of Ureter ¹¹ ³¹ ³³

Ureteral Calculi ⁷¹ ³³

Ureteric Stone ¹¹ ³³

Ureteral Calculus or Stone ³³

Ureterolithiasis Nos ³³

Stone in the Ureter ³³

Ureteric Calculus ¹¹

Ureter Calculi ³³

Ureterolith ³³

Classifications:

MalaCards categories:
Anatomical: Nephrological diseases

See all MalaCards categories (disease lists)

ICD10: ³¹

Diseases of the genitourinary system

Urolithiasis

Calculus of kidney and ureter

Calculus of ureter

ICD11: ³³

Diseases of the genitourinary system

Diseases of the urinary system

Urolithiasis

Calculus of upper urinary tract

Calculus of ureter

External Ids:

Disease Ontology ¹¹ DOID:14146

ICD9CM ³⁴ 592.1

MeSH ⁴³ D053039

NCIt ⁴⁹ C114696

SNOMED-CT ⁶⁸ 31054009

ICD10 ³¹ N20.1

EFO ¹⁶ EFO_1001228

ICD11 ³³ 1920593940

UMLS ⁷¹ C0041952 C1456865

Sources

Summaries for Ureterolithiasis

Disease Ontology: ¹¹ An ureteral disease this is characterized by the formation of stoney concentrations in the ureter.

MalaCards based summary: Ureterolithiasis, also known as calculus of ureter, is related to nephrolithiasis and hydronephrosis. An important gene associated with Ureterolithiasis is ADRA1A (Adrenoceptor Alpha 1A), and among its related pathways/superpathways are 4-hydroxyproline degradation and Sympathetic Nerve Pathway (Neuroeffector Junction). The drugs Sodium citrate and Sildenafil have been mentioned in the context of this disorder. Affiliated tissues include kidney, spinal cord and adrenal gland.

Wikipedia: ⁷⁵ Kidney stone disease, also known as nephrolithiasis or urolithiasis, is a crystallopathy where a solid... more...

Sources

Related Diseases for Ureterolithiasis

Diseases related to Ureterolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 406)

#	Related Disease	Score	Top Affiliating Genes
1	nephrolithiasis	30.4	PTH GRHPR F2 AGXT
2	hydronephrosis	30.3	KLK3 CRP ALB
3	prostatic hyperplasia, benign	30.3	PDE5A KLK3 ADRA1A
4	urolithiasis	30.2	F2 ALB AGXT
5	urethral calculus	30.1	KLK3 GRHPR
6	adenine phosphoribosyltransferase deficiency	30.0	GRHPR AGXT
7	urinary tract obstruction	29.9	KLK3 CRP ALB
8	peritonitis	29.8	F2 CRP ALB
9	acute pyelonephritis	29.8	CRP ALB
10	chronic pyelonephritis	29.8	PTH CRP ALB
11	cystic kidney disease	29.8	PTH CRP ALB
12	renal tuberculosis	29.7	CRP ALB AGXT
13	hyperphosphatemia	29.7	PTH CRP ALB
14	uremia	29.7	PTH CRP ALB
15	hyperuricemia	29.7	PTH CRP ALB
16	anuria	29.7	F2 CRP ALB
17	nephrocalcinosis	29.7	GRHPR ALB AGXT
18	hypertensive encephalopathy	29.7	F2 CRP ALB
19	chronic kidney disease	29.7	PTH CRP ALB AGXT
20	urethral stricture	29.7	PDE5A KLK3 CRP ADRA1D
21	urogenital tuberculosis	29.6	KLK3 CRP ALB
22	paralytic ileus	29.6	F2 CRP ALB
23	urinary tract infection	29.6	KLK3 F2 CRP ALB
24	pyuria	29.4	KLK3 F2 CRP ALB
25	schistosomiasis	29.4	F2 CRP ALB
26	neurogenic bladder	29.4	PDE5A KLK3 CRP ALB
27	kidney disease	29.1	PTH F2 CRP ALB AGXT
28	prostatic hypertrophy	29.0	PDE5A KLK3 CRP ALB ADRA1D ADRA1A
29	nephrolithiasis, calcium oxalate	10.6
30	ureteral obstruction	10.4
31	pulmonary valve insufficiency	10.3	PDE5A CRP
32	dental abscess	10.3	PTH CRP
33	pyelonephritis	10.3
34	appendicitis	10.3
35	enthesopathy	10.2	PTH CRP
36	diastolic heart failure	10.2	PDE5A CRP
37	diffuse idiopathic skeletal hyperostosis	10.2	PTH CRP
38	toxic shock syndrome	10.2
39	ileus	10.2
40	bursitis	10.2	PTH CRP
41	japanese spotted fever	10.2	IRGC CRP
42	orbital osteomyelitis	10.2	F2 CRP
43	achenbach syndrome	10.2	F2 CRP
44	bladder neck obstruction	10.2	PDE5A KLK3
45	synovial angioma	10.2	F2 CRP
46	emphysematous cholecystitis	10.2	F2 CRP
47	femoral neuropathy	10.2	F2 CRP
48	blue toe syndrome	10.2	F2 CRP
49	renal pelvis squamous cell carcinoma	10.2	F2 CRP
50	subclavian steal syndrome	10.2	F2 CRP

Comorbidity relations with Ureterolithiasis via Phenotypic Disease Network (PDN): (show all 12)

Acute Cystitis	Bladder Neck Obstruction
Hydronephrosis	Nephrolithiasis, Uric Acid
Nephrolithiasis, X-Linked Recessive, with Renal Failure	Paralytic Ileus
Prostate Cancer	Prostatic Hypertrophy
Pyelonephritis	Urethral Calculus
Urethral Stricture	Urinary Tract Obstruction

Graphical network of the top 20 diseases related to Ureterolithiasis:

Sources

Symptoms & Phenotypes for Ureterolithiasis

Sources

Drugs & Therapeutics for Ureterolithiasis

Drugs for Ureterolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 76)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Sodium citrate

Approved, Investigational

Phase 4

68-04-2

23431961

Sildenafil

Approved, Investigational

Phase 4

139755-83-2, 171599-83-0

5212 135398744

Nefopam

Approved, Investigational

Phase 4

13669-70-0

4450

Ketoprofen

Approved, Vet_approved

Phase 4

22071-15-4

3825

Morphine

Approved, Investigational

Phase 4

57-27-2

5288826

Parecoxib

Approved

Phase 4

198470-84-7

119828

Ketorolac

Approved

Phase 4

74103-06-3, 66635-83-4

3826

Oxycodone

Approved, Illicit, Investigational

Phase 4

76-42-6

5284603

Ciprofloxacin

Approved, Investigational

Phase 4

85721-33-1, 93107-08-5

2764

Tadalafil

Approved, Investigational

Phase 4

171596-29-5

110635

Tamsulosin

Approved, Investigational

Phase 4

106133-20-4

129211

Silodosin

Approved

Phase 4

160970-54-7

9891967 5312125

Citric acid

Approved, Nutraceutical, Vet_approved

Phase 4

77-92-9

311

Naftopidil

Investigational

Phase 4

57149-07-2

4418

Neurotransmitter Agents

Phase 4

Adrenergic Antagonists

Phase 4

Adrenergic alpha-Antagonists

Phase 4

Adrenergic Agents

Phase 4

Hormones

Phase 4

Antihypertensive Agents

Phase 4

Calcium, Dietary

Phase 4

calcium channel blockers

Phase 4

Platelet Aggregation Inhibitors

Phase 4

Citrate

Phase 4

Antipyretics

Phase 4

Ketorolac Tromethamine

Phase 4

Analgesics, Opioid

Phase 4

Narcotics

Phase 4

Antibiotics, Antitubercular

Phase 4

Anti-Bacterial Agents

Phase 4

Anti-Infective Agents

Phase 4

Cytochrome P-450 Enzyme Inhibitors

Phase 4

Vasodilator Agents

Phase 4

Phosphodiesterase Inhibitors

Phase 4

Phosphodiesterase 5 Inhibitors

Phase 4

Calcium

Nutraceutical

Phase 4

7440-70-2

271

Doxazosin

Approved

Phase 3

74191-85-8

3157

Nifedipine

Approved

Phase 3

21829-25-4

4485

Prazosin

Approved

Phase 3

19216-56-9

4893

Aceclofenac

Approved, Investigational

Phase 3

89796-99-6

71771

Tramadol

Approved, Investigational

Phase 3

27203-92-5

33741 5523

Furosemide

Approved, Vet_approved

Phase 3

54-31-9

3440

Midazolam

Approved, Illicit

Phase 3

59467-70-8

4192

Tocolytic Agents

Phase 3

Sodium Potassium Chloride Symporter Inhibitors

Phase 3

diuretics

Phase 3

Mirabegron

Approved

Phase 2

223673-61-8

18319735 9865528

Adrenergic beta-Agonists

Phase 2

Adrenergic beta-3 Receptor Agonists

Phase 2

Adrenergic Agonists

Phase 2

Interventional clinical trials:

(show top 50) (show all 88)

#	Name	Status	NCT ID	Phase	Drugs
1	The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study	Unknown status	NCT00489112	Phase 4	Alfuzocine XL 10 mg once a day
2	Role of Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) in Management of Distal Ureteral Stone	Unknown status	NCT02519153	Phase 4	Sildenafil
3	A Comparison Between Flexible Ureteroscopy, Semirigid Ureteroscopy and Extracorporeal Shockwaves Lithotripsy (SWL) in The Management of Proximal Ureteric Stones. A Randomized Controlled Trial	Unknown status	NCT02469766	Phase 4
4	Efficacy of Tamsulosin OCAS in the Conjunctive Medical Treatment of Distal Ureteral Stones.A Randomized, Double-blind, Placebo-controlled Study	Unknown status	NCT01167062	Phase 4	Tamsulosin Hydrochloride OCAS 0.4 mg
5	The Effectiveness and Safety of Naftopidil 75mg for Improving Clearance of Ureteral and Renal Stones After Shockwave Lithotripsy: Prospective Randomized Controlled Study	Unknown status	NCT02011737	Phase 4	naftopidil 75mg
6	Interest of Néfopam in the Treatment of Pain During the Intense Ureteral Calculi Uncomplicated in Adults in Emergencies Unit.	Completed	NCT00639574	Phase 4	Néfopam
7	Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Due to Ureteric Calculi: Randomized Controlled Trial	Completed	NCT03704623	Phase 4	Paracetamol;Parecoxib
8	Study of Tamsulosin for Urolithiasis in the Emergency Department	Completed	NCT00382265	Phase 4	tamsulosin
9	Study of Ketorolac Versus Opioid for Pain After Endoscopy (SKOPE): A Double-blinded Randomized Control Trial Comparing Outpatient Analgesic Efficacy of NSAIDs and Opioids in Patients Undergoing Ureteroscopy for Kidney Stones	Completed	NCT03888144	Phase 4	Oxycodone;Ketorolac
10	A 4-week, Double-blind, Randomized, Comparative and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones.	Completed	NCT01533389	Phase 4	Silodosin;Placebo
11	A Multicenter Randomized Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on Reducing Urinary Tract Infection	Recruiting	NCT03692715	Phase 4	Ciprofloxacin;Placebo
12	Comparative Study Between Tadalafil Versus Tamsulosin as a Medical Expulsive Therapy for Lower Ureteric Stones	Active, not recruiting	NCT04641507	Phase 4	Tadalafil versus tamsulosin as MET
13	Efectividad de la Tamsulosina Como Tratamiento Adyuvante Previo a Ureterolitotomia Endoscopica	Terminated	NCT03614052	Phase 4	Tamsulosin Hydrochloride 0.4 milligrams;Placebo Oral Tablet
14	Comparison of Silodosin vs. Tamsulosin on Spontaneous Passage of Acutely Obstructing Ureteral Calculi in Medical Expulsive Therapy	Terminated	NCT02369744	Phase 4	Silodosin;Tamsulosin
15	Celecoxib in the Management of Acute Renal Colic	Withdrawn	NCT00304317	Phase 4	celecoxib
16	Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones	Unknown status	NCT00713739	Phase 3	Alfuzosin;nifedipine;doxazosin;prazosin
17	Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones	Completed	NCT00151567	Phase 3	Tamsulosin;Placebo
18	Medical Expulsive Therapy for Ureter Stone Using Naftopidil: Multicenter, Randomized, Double-blind, Placebo Controlled Study	Completed	NCT01952314	Phase 3	Naftopidil 75mg;Placebo for Naftopidil;Standard treatment
19	Effect of Perioperative Selective alpha1-blockers in Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones	Completed	NCT04557202	Phase 3	Tamsulosin Oral Capsule;Placebo
20	Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi	Completed	NCT00177086	Phase 3
21	Effect of Furosemide on Outcome of Extracorporeal Shock Wave Lithotripsy for Renal and Ureteral Calculi; a Randomized, Triple-blinded, Controlled Trial	Recruiting	NCT05270421	Phase 3	Furosemide 40 mg
22	Phase II Study Comparing Two Groups of Patients Undergoing ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin	Unknown status	NCT00478998	Phase 2	Tamsulosin
23	Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL.	Unknown status	NCT00409227	Phase 2	Alpha blocker-alfuzosin;placebo
24	A Double Blind Placebo Control Trial of Mirabegron for Medical Expulsive Therapy and to Manage Stent Pain for Ureteral Stones(Protocol # 01-16-20-02)	Completed	NCT02744430	Phase 2	Mirabegron
25	Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract	Completed	NCT04695951	Phase 2
26	A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage	Completed	NCT01144949	Phase 2	silodosin;placebo
27	URIPRENE: Feasibility Study to Evaluate the Preliminary Safety and Effectiveness of the Uriprene Stent Following Uncomplicated Ureteroscopy	Completed	NCT02032316	Phase 1
28	Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During	Unknown status	NCT02279927
29	The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms: A Prospective Randomized Study	Unknown status	NCT03274700	Early Phase 1	Tamsulosin.;Placebo.
30	External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone: A Multi-center Prospective Randomized Controlled Trial	Unknown status	NCT03730389
31	Does Preoperative Tamsulosin Facilitate Semi-rigid Ureteroscopic Management of Lower Ureteric Calculi Prospective, Randomized Double Blind Study	Unknown status	NCT04602403
32	The Impact of Silent Ureteral Stone on Renal Function and Kidney Anatomy: a Prospective Analysis	Unknown status	NCT01884870
33	Randomized Controlled Trial Comparing Surgical Outcomes Following PCNL Under Ultrasound Control and PCNL Under Fluoroscopic Control in the Treatment of Kidney Stones	Unknown status	NCT04606758
34	Staged Ureteroscopy After Initial Urinary Drainage Versus Direct Ureteroscopy in the Treatment of Pediatric Obstructive Calcular Anuria	Unknown status	NCT02139059
35	Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone	Unknown status	NCT00397397
36	The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones. A Randomized Clinical Trial	Unknown status	NCT03243682
37	Shockwave Lithotripsy (SWL) Under Regular General Anesthesia and Under General Anesthesia Using Bronchial Blocker.	Unknown status	NCT01008267
38	Influence of Patient Decision-Making Aids for Patients With Unilateral Ureteral Stone: A Randomized-Controlled Trial	Unknown status	NCT04504084
39	Intraureteral of Alkalinized Lidocaine as Novel Approach to Post-Ureteroscopy Pain: Double-blind Prospective Randomized Controlled Trial	Unknown status	NCT01450566		Lidocaine;Saline
40	Effectiveness of Drainage of the Kidney by Percutaneous Nephrostomy Catheter Placement Vs. Retrograde Double J Catheter Placement in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis	Unknown status	NCT04594161
41	Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis	Completed	NCT00762424		Flowmax;placebo
42	Ultrasound Non-contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up	Completed	NCT02539004
43	Ureteroscopic Lithotripsy in the Reverse Trendelenburg Position for Upper Ureteral Stones: a Prospective, Randomized, Comparative Study	Completed	NCT04894058
44	Medical Expulsive Therapy of Single Distal Ureteral Stones. A Randomised, Double-blind and Placebo-controlled Study	Completed	NCT00831701		Tamsulosin;Placebo
45	Comparison of Pro Seal and Baska-mask	Completed	NCT04186455
46	Comparison Between Symptomps Related to Pigtail Suture Stent Versus Conventional Double J After Ureterorenoscopy for Stone Treatment. A Prospective Randomized Trial	Completed	NCT03344120
47	Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone	Completed	NCT03726502
48	The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcome of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter	Completed	NCT00517205
49	The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients	Completed	NCT00448123		Tamsulosin;Placebo
50	Ultraslow Full-power SWL Versus Slow SWL in Stones With High Attenuation Value	Completed	NCT03795545

Search NIH Clinical Center for Ureterolithiasis

Cochrane evidence based reviews: ureterolithiasis

Sources

Genetic Tests for Ureterolithiasis

Sources

Anatomical Context for Ureterolithiasis

Organs/tissues related to Ureterolithiasis:

MalaCards : Kidney, Spinal Cord, Adrenal Gland, Smooth Muscle, Neutrophil, Prostate, Colon

Sources

Publications for Ureterolithiasis

Articles related to Ureterolithiasis:

(show top 50) (show all 2529)

#	Title	Authors	PMID	Year
1	Predictive factors for stone management timing after emergency percutaneous nephrostomy drainage in patients with infection and hydronephrosis secondary to ureteral calculi. ⁶²	Hsu CK...Wu SY	36454363	2022
2	Randomized comparison of 4.5/6 Fr versus 6/7.5 Fr ureteroscopes for laser lithotripsy of lower/middle ureteral calculi: towards optimization of efficacy and safety of semirigid ureteroscopy. ⁶²	Omar M...Noureldin YA	36208314	2022
3	Ureteral calculi lithotripsy for single ureteral calculi: can DNN-assisted model help preoperatively predict risk factors for sepsis? ⁶²	Chen M...Li Z	35731290	2022
4	A systematic review and meta-analysis of clinical signs, symptoms, and imaging findings in patients with suspected renal colic. ⁶²	Dahm P...Raja AS	36474707	2022
5	Acute extracorporeal shockwave lithotripsy for ureteric stones - 7-years' experience from a busy district general hospital. ⁶²	Young MJ...Symons SJ	35689415	2022
6	Upper ureteral calculi complicated with severe hydronephrosis and renal medullary carcinoma in elderly Chinese woman: A case report. ⁶²	Yu Q...Jiang R	36450622	2022
7	A giant ureteric calculus successfully removed by mini-endoscopic combined intrarenal surgery: A case report. ⁶²	Limudomporn P...Ketsuwan C	36337173	2022
8	Obstructing Ureteral Calculi and Presumed Infection: Impact of Antimicrobial Duration and Time From Decompression to Stone Treatment in Developing Urosepsis. ⁶²	Orr A...Sternberg K	36334770	2022
9	Ambulatory Minimally-invasive Endoscopic Combined Intra-Renal Surgery in management of Large Impacted Proximal Ureteral Calculi: A feasibility study at a tertiary referral centre. ⁶²	Mishra DK...Gauhar V	36401507	2022
10	A pediatric case of ureterolithiasis due to cystinuria accompanied by acute appendicitis; a case report. ⁶²	Hiraoka T...Moriwake T	36115118	2022
11	Where are the paediatric patients with testicular torsion during the COVID-19 pandemic? ⁶²	Norton SM...D'Arcy F	34664222	2022
12	Regeneration of the ureter using a scaffold-free live-cell structure created with the bio-three-dimensional printing technique. ⁶²	Takagi K...Nagayasu T	36243376	2022
13	Impact of Stone Localization before Emergency Ureteral Stenting on Further Stone Treatment. ⁶²	Huettenbrink C...Distler FA	36282063	2022
14	Ureterolithiasis in unilateral duplex kidney with completely duplicated ureters. ⁶²	Huang HH...Cheng PY	35780030	2022
15	Factors Affecting the Outcome of Medical Treatment in Cats with Obstructive Ureteral Stones Treated with Tamsulosin: 70 Cases (2018-2022). ⁶²	Chae HK...Hong YJ	36288181	2022
16	Risk of future stroke in patients with a diagnosis of peripheral vertigo in the emergency department. ⁶²	Choi JY...Kim JS	36056876	2022
17	Choosing the best way for urinary decompression and developing a novel predictive model for septic shock using SOFA in these patients. ⁶²	Law YXT...Lee KCJ	36070249	2022
18	Community-onset urosepsis: incidence and risk factors for 30-day mortality - a retrospective cohort study. ⁶²	Holmbom M...Aljabery F	36127849	2022
19	Management of encrusted ureteral stents: Two center experience. ⁶²	Thangavelu M...Kotb A	36165475	2022
20	Efficacy of ultrasound monitoring during extracorporeal shock wave lithotripsy: A multi-institutional propensity score-matched study. ⁶²	Isogai M...Yasui T	35871263	2022
21	Low-Dose CT for Renal Calculi Detection Using Spectral Shaping of High Tube Voltage. ⁶²	Gassenmaier S...Bongers MN	35272363	2022
22	Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study. ⁶²	Byrne MHV...COVID Stones Collaborative	36083711	2022
23	Transvesicoscopic ureteral reimplantation and ureteroscopy for management of primary obstructed non-refluxing megaureter with ureteral calculus. ⁶²	Kato T...Hayashi Y	36090926	2022
24	Reducing the rate of negative ureteroscopy: predictive factors and the role of preoperative imaging. ⁶²	Brodie AC...Keoghane SR	35133211	2022
25	Impact of forced diuresis on retropulsion of disintegrated ureteral calculi during semi-rigid ureteroscopy: a double-blind randomized-controlled study. ⁶²	Shalaby EA...Elkoushy MA	35451636	2022
26	Therapeutic Living Donor Nephrectomy for Proximal Ureteral Pathology: A Longitudinal Case Series. ⁶²	Freise J...Roll GR	35550384	2022
27	Symptomatic Hydronephrosis and Ureteral Calculi in Pregnancy: A Narrative Review with a Proposed Management Protocol. ⁶²	Keenan RA...Davis NF	35345895	2022
28	Potential Markers to Reduce Non-Contrast Computed Tomography Use for Symptomatic Patients with Suspected Ureterolithiasis. ⁶²	Avda Y...Shilo Y	36013299	2022
29	The role of a urine dipstick in the diagnosis of the acute scrotum. ⁶²	Tissot S...Grills R	35783592	2022
30	Open Ureteric Exploration in Aminu Kano Teaching Hospital: Indications and Outcome. ⁶²	Sani A...Alhassan SU	36388738	2022
31	The effect of perirenal fat stranding on infectious complications after ureterorenoscopy in patients with ureteral calculi. ⁶²	Demirelli E...Oguz U	36035336	2022
32	Construction of a novel rabbit model of ureteral calculi implanted with flowable resin. ⁶²	Su H...Zhu J	35850713	2022
33	Massive Ureterolithiasis. ⁶²	Zaman S...Ganti L	36039196	2022
34	A rare complication of percutaneous nephrolithotomy: Jejunal perforation and its management. ⁶²	Meganathan S...Asmgbb A	35300354	2022
35	Laparoscopic surgery for renal cyst and upper ureteral calculi in patients with duplex kidney: A case report. ⁶²	Hou H...Liu Y	35843816	2022
36	An unusual case of spontaneous rupture of the renal pelvis. ⁶²	Weber T...Ricchiuti D	35368982	2022
37	Intravesical aminophylline instillation as an alternative for balloon dilatation prior to semi-rigid ureteroscopic management of distal ureteral stones. ⁶²	Shabayek M...Saafan A	35618855	2022
38	Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis. ⁶²	Grossmann NC...Kranzbuhler B	35441879	2022
39	Clinical Low Dose Photon Counting CT for the Detection of Urolithiasis: Evaluation of Image Quality and Radiation Dose. ⁶²	Niehoff JH...Kroeger JR	35894003	2022
40	Sheathed flexible retrograde intrarenal surgery without safety guide wire for upper urinary tract stones. ⁶²	Asali M	35775345	2022
41	Effect of targeting and generator type on efficacy of extracorporeal shock wave lithotripsy. ⁶²	Motolova M...Kral M	35801399	2022
42	A simple predictive model with internal validation for assessment of stone-left after ureteroscopic lithotripsy in upper ureteral stones. ⁶²	Wu W...Yu X	35812191	2022
43	Successful Treatment of Ureteral Obstructive Lithiasis by Ureterotomy in a Domestic Hen. ⁶²	Modesto F...van Bruggen LWL	35526167	2022
44	Obstructive struvite ureterolithiasis in 4-month-old intact male Bernese mountain dog. ⁶²	Ho J...Lavallee J	35502263	2022
45	A multicenter, double-blind, placebo-controlled parallel study to evaluate the role of Yinhua Miyanling tablets in the prevention of bacterial biofilm formation on ureteral stents: a randomised trial. ⁶²	Du Z...Chen S	35672892	2022
46	Retrograde intrarenal surgery for impacted upper ureteral stone in a patient with advanced lumbar scoliosis and lower-extremity development defect: a case report. ⁶²	Guler Y	35614450	2022
47	The Efficacy of Sexual Intercourse Or Masturbation For The Expulsion Of Distal Ureteral Stones In Men: A Systematic Review And Meta-analysis Of Randomized-controlled Trials. ⁶²	Lu Y...Li H	35598041	2022
48	The use of 14/16Fr ureter access sheath for safe and effective management of large upper ureteral calculi. ⁶²	Tsaturyan A...Kallidonis P	35150299	2022
49	Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria. ⁶²	Russom M...Bahta M	35170870	2022
50	Efficacy of supine trans-abdominal pronated shock head ESWL for treatment of distal ureteric stones: A pilot study. ⁶²	Sarkar D...Pal DK	35422154	2022

Sources

Genes for Ureterolithiasis

Genes related to Ureterolithiasis (0 elite genes):

(show all 13)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	ADRA1A	Adrenoceptor Alpha 1A	Protein Coding	6.06	DISEASES inferred ¹⁴
2	PDE5A	Phosphodiesterase 5A	Protein Coding	5.9	DISEASES inferred ¹⁴
3	CRP	C-Reactive Protein	Protein Coding	5.82	DISEASES inferred ¹⁴
4	ADRA1D	Adrenoceptor Alpha 1D	Protein Coding	5.66	DISEASES inferred ¹⁴
5	PTH	Parathyroid Hormone	Protein Coding	5.38	DISEASES inferred ¹⁴
6	AGXT	Alanine--Glyoxylate Aminotransferase	Protein Coding	5.33	DISEASES inferred ¹⁴
7	GLYCTK	Glycerate Kinase	Protein Coding	5.24	DISEASES inferred ¹⁴
8	GRHPR	Glyoxylate And Hydroxypyruvate Reductase	Protein Coding	5.06	DISEASES inferred ¹⁴
9	IRGC	Immunity Related GTPase Cinema	Protein Coding	4.94	DISEASES inferred ¹⁴
10	KLK3	Kallikrein Related Peptidase 3	Protein Coding	4.84	DISEASES inferred ¹⁴
11	TAF8	TATA-Box Binding Protein Associated Factor 8	Protein Coding	4.73	DISEASES inferred ¹⁴
12	ALB	Albumin	Protein Coding	4.63	DISEASES inferred ¹⁴
13	F2	Coagulation Factor II, Thrombin	Protein Coding	4.55	DISEASES inferred ¹⁴

Sources

Variations for Ureterolithiasis

Sources

Expression for Ureterolithiasis

Search GEO for disease gene expression data for Ureterolithiasis.

Sources

Pathways for Ureterolithiasis

Pathways related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	4-hydroxyproline degradation ⁶¹ Show member pathways Glyoxylate metabolism ⁷⁴ L-proline degradation ⁶¹ Proline catabolism ⁶⁶ proline degradation ⁶¹ trans-4-hydroxy-L-proline degradation I ⁶¹	10.35	GRHPR AGXT
2	Sympathetic Nerve Pathway (Neuroeffector Junction) ⁶⁰	9.98	ADRA1D ADRA1A

Sources

GO Terms for Ureterolithiasis

Biological processes related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	neuron-glial cell signaling	GO:0150099	9.46	ADRA1D ADRA1A
2	adrenergic receptor signaling pathway	GO:0071875	9.26	ADRA1D ADRA1A
3	glyoxylate metabolic process	GO:0046487	9.26	GRHPR AGXT
4	positive regulation of heart rate by epinephrine-norepinephrine	GO:0001996	8.92	ADRA1D ADRA1A